"Designing Growth Strategies is in our DNA"

Dementia Drugs Market Size, Share & Industry Analysis, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Amyloid Beta-directed Antibodies), By Indication (Alzheimer's Disease and Parkinson's Disease Dementia), By Type (Branded and Generics), By Route of Administration (Oral, Parenteral, and Others), By Treatment Type (Symptomatic Cognitive Therapies, Disease-modifying Therapies, and Behavioral & Neuropsychiatric Symptom Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: August 13, 2026 | Format: PDF | Report ID: FBI118891

 

Buy Now

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries/Region
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    3. New Product Launches, By Key Players
    4. Pipeline Analysis, By Key Players
    5. Regulatory & Reimbursement Scenario, By Key Countries/Region
  5. Global Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Eisai Inc. 
      2. Eli Lilly and Company
      3. Biogen Inc.
      4. Otsuka Pharmaceutical, Inc 
      5. H. Lundbeck A/S
      6. AbbVie Inc.
      7. Novartis AG
      8. Alpha Cognition
      9. Teva Pharmaceutical Industries Ltd.
      10. Viatris Inc.
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Challenges
    5. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, By Key Countries/Region
    2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    3. New Product Launches, By Key Players
    4. Pipeline Analysis, By Key Players
    5. Regulatory & Reimbursement Scenario, By Key Countries/Region
  5. Global Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – Region
      1.  North America
      2.  Europe
      3.  Asia Pacific
      4.  Latin America
      5.  Middle East & Africa
  6. North America Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada 
  7. Europe Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. U.K.
      2. Germany 
      3. France 
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Dementia Drugs Market Analysis, Insights and Forecast, 2021-2034 
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. NMDA Receptor Antagonists
      3. Amyloid Beta-directed Antibodies
      4. Others
    2. Market Analysis, Insights and Forecast – By Indication
      1. Alzheimer’s Disease
      2. Parkinson’s Disease Dementia 
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
      3. Others
    4. Market Analysis, Insights and Forecast – By Type
      1. Branded 
      2. Generics
    5. Market Analysis, Insights and Forecast – By Treatment Type
      1. Symptomatic Cognitive Therapies
      2. Disease-modifying Therapies
      3. Behavioral and Neuropsychiatric Symptom Therapies
      4. Others 
    6. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies 
      4. Others
    7. Market Analysis, Insights and Forecast – By Country/ Sub-Region
      1. GCC 
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis 
    1. Global Market Share Analysis (2025)
    2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability)
      1. Eisai Inc. 
      2. Eli Lilly and Company
      3. Biogen Inc.
      4. Otsuka Pharmaceutical, Inc 
      5. H. Lundbeck A/S
      6. AbbVie Inc.
      7. Novartis AG
      8. Alpha Cognition
      9. Teva Pharmaceutical Industries Ltd.
      10. Viatris Inc.
Read Less

Figure 1:  Global Dementia Drugs Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034

Figure 2:  Global Dementia Drugs Market Value Share (%), By Drug Class, 2025 & 2034

Figure 3:  Global Dementia Drugs Market Value Share (%), By Indication, 2025 & 2034

Figure 4:  Global Dementia Drugs Market Value Share (%), By Route of Administration, 2025 & 2034

Figure 5:  Global Dementia Drugs Market Value Share (%), By Type, 2025 & 2034

Figure 6:  Global Dementia Drugs Market Value Share (%), By Treatment Type, 2025 & 2034

Figure 7:  Global Dementia Drugs Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 8:  Global Dementia Drugs Market Value Share (%), By Region, 2025 & 2034

Figure 9:  North America Dementia Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 10:  North America Dementia Drugs Market Value Share (%), By Drug Class, 2025

Figure 11:  North America Dementia Drugs Market Value (USD billion), By Indication, 2025 & 2034

Figure 12:  North America Dementia Drugs Market Value Share (%), By Indication, 2025

Figure 13:  North America Dementia Drugs Market Value (USD billion), By Route of Administration, 2025 & 2034

Figure 14:  North America Dementia Drugs Market Value Share (%), By Route of Administration, 2025

Figure 15:  North America Dementia Drugs Market Value (USD billion), By Type, 2025 & 2034

Figure 16:  North America Dementia Drugs Market Value Share (%), By Type, 2025

Figure 17:  North America Dementia Drugs Market Value (USD billion), By Treatment Type, 2025 & 2034

Figure 18:  North America Dementia Drugs Market Value Share (%), By Treatment Type, 2025

Figure 19:  North America Dementia Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 20:  North America Dementia Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 21:  North America Dementia Drugs Market Value (USD billion), by Country, 2025 & 2034

Figure 22:  North America Dementia Drugs Market Value Share (%), by Country, 2025

Figure 23:  Europe Dementia Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 24:  Europe Dementia Drugs Market Value Share (%), By Drug Class, 2025

Figure 25:  Europe Dementia Drugs Market Value (USD billion), By Indication, 2025 & 2034

Figure 26:  Europe Dementia Drugs Market Value Share (%), By Indication, 2025

Figure 27:  Europe Dementia Drugs Market Value (USD billion), By Route of Administration, 2025 & 2034

Figure 28:  Europe Dementia Drugs Market Value Share (%), By Route of Administration, 2025

Figure 29:  Europe Dementia Drugs Market Value (USD billion), By Type, 2025 & 2034

Figure 30:  Europe Dementia Drugs Market Value Share (%), By Type, 2025

Figure 31:  Europe Dementia Drugs Market Value (USD billion), By Treatment Type, 2025 & 2034

Figure 32:  Europe Dementia Drugs Market Value Share (%), By Treatment Type, 2025

Figure 33:  Europe Dementia Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 34:  Europe Dementia Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 35:  Europe Dementia Drugs Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 36:  Europe Dementia Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 37:  Asia Pacific Dementia Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 38:  Asia Pacific Dementia Drugs Market Value Share (%), By Drug Class, 2025

Figure 39:  Asia Pacific Dementia Drugs Market Value (USD billion), By Indication, 2025 & 2034

Figure 40:  Asia Pacific Dementia Drugs Market Value Share (%), By Indication, 2025

Figure 41:  Asia Pacific Dementia Drugs Market Value (USD billion), By Route of Administration, 2025 & 2034

Figure 42:  Asia Pacific Dementia Drugs Market Value Share (%), By Route of Administration, 2025

Figure 43:  Asia Pacific Dementia Drugs Market Value (USD billion), By Type, 2025 & 2034

Figure 44:  Asia Pacific Dementia Drugs Market Value Share (%), By Type, 2025

Figure 45:  Asia Pacific Dementia Drugs Market Value (USD billion), By Treatment Type, 2025 & 2034

Figure 46:  Asia Pacific Dementia Drugs Market Value Share (%), By Treatment Type, 2025

Figure 47:  Asia Pacific Dementia Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 48:  Asia Pacific Dementia Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 49:  Asia Pacific Dementia Drugs Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 50:  Asia Pacific Dementia Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 51:  Latin America Dementia Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 52:  Latin America Dementia Drugs Market Value Share (%), By Drug Class, 2025

Figure 53:  Latin America Dementia Drugs Market Value (USD billion), By Indication, 2025 & 2034

Figure 54:  Latin America Dementia Drugs Market Value Share (%), By Indication, 2025

Figure 55:  Latin America Dementia Drugs Market Value (USD billion), By Route of Administration, 2025 & 2034

Figure 56:  Latin America Dementia Drugs Market Value Share (%), By Route of Administration, 2025

Figure 57:  Latin America Dementia Drugs Market Value (USD billion), By Type, 2025 & 2034

Figure 58:  Latin America Dementia Drugs Market Value Share (%), By Type, 2025

Figure 59:  Latin America Dementia Drugs Market Value (USD billion), By Treatment Type, 2025 & 2034

Figure 60:  Latin America Dementia Drugs Market Value Share (%), By Treatment Type, 2025

Figure 61:  Latin America Dementia Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 62:  Latin America Dementia Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 63:  Latin America Dementia Drugs Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 64:  Latin America Dementia Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 65:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Drug Class, 2025 & 2034

Figure 66:  Middle East & Africa Dementia Drugs Market Value Share (%), By Drug Class, 2025

Figure 67:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Indication, 2025 & 2034

Figure 68:  Middle East & Africa Dementia Drugs Market Value Share (%), By Indication, 2025

Figure 69:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Route of Administration, 2025 & 2034

Figure 70:  Middle East & Africa Dementia Drugs Market Value Share (%), By Route of Administration, 2025

Figure 71:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Type, 2025 & 2034

Figure 72:  Middle East & Africa Dementia Drugs Market Value Share (%), By Type, 2025

Figure 73:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Treatment Type, 2025 & 2034

Figure 74:  Middle East & Africa Dementia Drugs Market Value Share (%), By Treatment Type, 2025

Figure 75:  Middle East & Africa Dementia Drugs Market Value (USD billion), By Distribution Channel, 2025 & 2034

Figure 76:  Middle East & Africa Dementia Drugs Market Value Share (%), By Distribution Channel, 2025

Figure 77:  Middle East & Africa Dementia Drugs Market Value (USD billion), by Country/ Sub-region, 2025 & 2034

Figure 78:  Middle East & Africa Dementia Drugs Market Value Share (%), by Country/ Sub-region, 2025

Figure 79:  Global Dementia Drugs Market Share (%), by Company, 2025

Table 1:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034 

Table 2:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 3:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 4:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 5:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 6:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 7:  Global Dementia Drugs Market Revenue (USD billion) Forecast, By Region, 2021-2034 

Table 8:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034 

Table 9:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 10:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 11:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 12:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 13:  North America Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 14:  North America Dementia Drugs Market Revenue (USD billion) Forecast, by Country, 2021-2034 

Table 15:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034 

Table 16:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 17:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 18:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 19:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 20:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 21:  Europe Dementia Drugs Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 22:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034 

Table 23:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 24:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 25:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 26:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 27:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 28:  Asia Pacific Dementia Drugs Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 29:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034

Table 30:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 31:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 32:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 33:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 34:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 35:  Latin America Dementia Drugs Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Table 36:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Drug Class, 2021-2034 

Table 37:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Indication, 2021-2034 

Table 38:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Route of Administration, 2021-2034 

Table 39:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Type, 2021-2034 

Table 40:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Treatment Type, 2021-2034 

Table 41:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034 

Table 42:  Middle East & Africa Dementia Drugs Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034 

Dementia Drugs Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 204
Download Free Sample

    man icon
    Mail icon
    Captcha refresh

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Customize Now
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports